Non-Randomised, Open Phase II Trial, Investigating Liposomal Irinotecan and 5-Fluorouraci Followed by Surgical Resection in Patients with Hepatic Oligometastatic Pancreatic Cancer (HOLIPANC). Issue 2 (February 2020)